PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma

被引：0
|
作者：
Verena Sailer
Emily Eva Holmes
Heidrun Gevensleben
Diane Goltz
Freya Dröge
Alina Franzen
Jörn Dietrich
Glen Kristiansen
Friedrich Bootz
Andreas Schröck
Dimo Dietrich
机构：
[1] Weill Cornell Medicine,Department of Pathology and Laboratory Medicine
[2] Weill Cornell Medicine,Caryl and Israel Englander Institute for Precision Medicine
[3] University Hospital Bonn,Institute of Pathology
[4] University Hospital Cologne,Institute of Pathology
[5] University Hospital Essen,Department of Otorhinolaryngology
[6] University of Duisburg-Essen,Department of Otolaryngology, Head and Neck Surgery
[7] University Hospital Bonn,undefined
来源：
Clinical Epigenetics | 2017年 / 9卷
关键词：
Biomarker; Head and neck squamous cell carcinoma; HNSCC; DNA methylation; HPV; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma
    Chen, Dayang
    Wang, Mengmeng
    Guo, Ying
    Wu, Wei
    Ji, Xiang
    Dou, Xiaowen
    Tang, Huamei
    Zong, Zengyan
    Zhang, Xiuming
    Xiong, Dan
    CANCER MEDICINE, 2021, 10 (17): : 5936 - 5947
  • [32] Serum Albumin as an Independent Predictor of Long-Term Survival in Patients with Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Treated with Nivolumab
    Suzuki, Shinsuke
    Taguchi, Yukie
    Kitabayashi, Takuro
    Sato, Nobuko
    Kaya, Haruka
    Abe, Tomoe
    Endo, Tentaro
    Suzuki, Hitomi
    Kawasaki, Yohei
    Yamada, Takechiyo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
  • [33] Thiazolidinedione (TZD) exposure and overall survival (OS) in squamous cell carcinoma of the head and neck (SCCHN)
    Govindarajan, R.
    Siegel, E. R.
    Simmons, D. L.
    Lang, N. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] SULF2 expression is prognostic for overall survival in Head and Neck Squamous Cell Carcinoma
    Yang, Yang
    Ahn, Jaeil
    Kallakury, Bhaskar V.
    Brnakova, Zuzana
    Davidson, Bruce J.
    Goldman, Radoslav
    GLYCOBIOLOGY, 2018, 28 (12) : 1068 - 1069
  • [35] Low expression of RalGAPs associates with the poorer overall survival of head and neck squamous cell carcinoma
    Liu, Shan
    Shi, Congyu
    Wang, Xiaoyi
    Ma, Xiangrui
    Gao, Pan
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (12) : 5085 - +
  • [36] A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
    Wu, Huili
    Zhao, Xiao
    Zhu, Tingting
    Rong, Di
    Wang, Ying
    Leng, Diya
    Wu, Daming
    FRONTIERS IN GENETICS, 2022, 13
  • [37] Stability of methylation markers in head and neck squamous cell carcinoma
    Virani, Shama
    Light, Emily
    Peterson, Lisa A.
    Sartor, Maureen A.
    Taylor, Jeremy M. G.
    McHugh, Jonathan B.
    Wolf, Gregory T.
    Rozek, Laura S.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E1325 - E1331
  • [38] Gender disparities among race in the incidence and overall survival of head and neck squamous cell carcinoma
    Naik, A. N.
    Mazul, A.
    Zhan, K. Y.
    Puram, S. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1159 - 1159
  • [39] DNA methylation-mediated Klotho silencing is an independent prognostic biomarker of head and neck squamous carcinoma
    Zhu, Yun
    Cao, Xuehong
    Zhang, Xiaomeng
    Chen, Quan
    Wen, Lei
    Wang, Ping
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 1383 - 1390
  • [40] DNA methylation profiling in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.
    Starzer, Angelika Martina
    Heller, Gerwin
    Tomasich, Erwin
    Feldmann, Katharina
    Hatziioannou, Teresa
    Traint, Stefan
    Minichsdorfer, Christoph
    Schwarz-Nemec, Ursula
    Nackenhorst, Maja
    Muellauer, Leonhard
    Preusser, Matthias
    Berghoff, Anna Sophie
    Fuereder, Thorsten
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345